39 related articles for article (PubMed ID: 5802725)
1. Melanoma NOS1 expression promotes dysfunctional IFN signaling.
Liu Q; Tomei S; Ascierto ML; De Giorgi V; Bedognetti D; Dai C; Uccellini L; Spivey T; Pos Z; Thomas J; Reinboth J; Murtas D; Zhang Q; Chouchane L; Weiss GR; Slingluff CL; Lee PP; Rosenberg SA; Alter H; Yao K; Wang E; Marincola FM
J Clin Invest; 2014 May; 124(5):2147-59. PubMed ID: 24691438
[TBL] [Abstract][Full Text] [Related]
2. An immunologic portrait of cancer.
Ascierto ML; De Giorgi V; Liu Q; Bedognetti D; Spivey TL; Murtas D; Uccellini L; Ayotte BD; Stroncek DF; Chouchane L; Manjili MH; Wang E; Marincola FM
J Transl Med; 2011 Aug; 9():146. PubMed ID: 21875439
[TBL] [Abstract][Full Text] [Related]
3. [Electron microscopy autoradiography of labelled host cells in mouse melanomas].
Dvorák R; Eckhardt U
Arch Dermatol Forsch; 1972; 245(4):334-45. PubMed ID: 4641685
[No Abstract] [Full Text] [Related]
4. Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B; Nathanson L; Clark DA
Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
[No Abstract] [Full Text] [Related]
5. [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
Lischka G
Arch Dermatol Res (1975); 1975 Sep; 253(2):105-12. PubMed ID: 1190833
[TBL] [Abstract][Full Text] [Related]
6. [The immunology of malignant melanoma (author's transl)].
Schieferstein G
Klin Wochenschr; 1978 Mar; 53(16):241-53. PubMed ID: 355711
[No Abstract] [Full Text] [Related]
7. [Immunological exploration of cancer patients. II. Tumoral immunity].
Cappelaere P; Demaille A; Adenis L
Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
[No Abstract] [Full Text] [Related]
8. Regression of malignant melanoma as a manifestation of a cellular immunity response.
Lloyd OC
Proc R Soc Med; 1969 Jun; 62(6):543-5. PubMed ID: 5802725
[No Abstract] [Full Text] [Related]
9. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
10. Spontaneous regression of metastatic malignant melanoma.
McCarthy WH; Shaw HM; Milton GW
Clin Oncol; 1978 Sep; 4(3):203-7. PubMed ID: 750122
[No Abstract] [Full Text] [Related]
11. [Melanoma (Hutchinson's lentigo maligna) having spontaneous regression. A case of immunologic importance].
Grinspan D; Paz A; Abulafia J; Mosto S
Med Cutan Ibero Lat Am; 1980; 8(1-3):33-45. PubMed ID: 7022050
[TBL] [Abstract][Full Text] [Related]
12. [Spontaneous regression in malignant melanoma].
Avinoach I
Harefuah; 1992 May; 122(9):587-92. PubMed ID: 1526586
[No Abstract] [Full Text] [Related]
13. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
14. Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I.
PETERSEN NC; BODENHAM DC; LLOYD OC
Br J Plast Surg; 1962 Jan; 15():49-94. PubMed ID: 14485771
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
